1. Have you heard about pharmacogenetics before?
No - 7 votes (20%)
2.
Do you agree that biotechnology is an enabling tool in the field of medicine?
Yes - 41 votes (86%)
No - 0 votes (0%)
Maybe - 5 votes (10%)
Don't know - 2 votes (4%)
Total votes - 48
3. Do you think pharmacogenetics will be fully advanced one day?
Yes - 32 votes (82%)
No - 2 votes (5%)
Maybe - 5 votes (13%)
Don't know - 0 votes (0%)
Total votes - 39
4.
As pharmacogenetics advances, do you think drug development for a minority
group might be neglected due to lower profits?
Yes - 24 votes (64%)
No -5 votes (14%)
Maybe - 8 votes (22%)
Don't know - 0 votes (0%)
Total votes - 37
5.
Do you welcome research in pharmacogenetics?
Yes - 37 votes (92%)
No -0 votes (0%)
Maybe - 3 votes (8%)
Total votes - 40
For this month’s edition of the MABIC newsletter, readers were queried regarding their understanding of pharmacogenetics. 80% of readers had encountered the term pharmacogenetics before whereas it was something new for 20% of the readers polled.
Out of 48 readers questioned, an overwhelming 41 believed that biotechnology had the potential of revolutionising the medical scene, while a five maintained a wait-and-see attitude. Of the readers polled, 82% believed that pharmacogenetics would be fully advanced, in contrast to the 5% who gave an all out negative response and the 13% who maintained reservation.
Another area of concern was the focus of minority groups, as 65% believed that there is potential for neglect due to lower profit margins of minority groups, with 22% voicing the possibility and 14% believed the opposite.
In general,
readers polled were supportive of pharmacogenetics, with 37 out of the
40 polled giving unequivocal support to the field, while a minority of
three polled did not support the advancement of pharmacogenetics.
